DBV Technologies SA
For the period ended Mar 31, 2024. Filed May 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 7, 2024
DBVT$11.05+5.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Financial Statements
Condensed Consolidated Statements of Financial Position (unaudited)
(amounts in thousands, except share and per share data)
| March 31, · December 31, | |||
|---|---|---|---|
| Note | 2024 | 2023 | |
| Assets | |||
| Current assets: | |||
| Cash and cash equivalents | 3 | $101,525 | $141,367 |
| Other current assets | 4 | 18,037 | 17,548 |
| Total current assets | 119,562 | 158,915 | |
| Property, plant, and equipment, net | 12,913 | 12,623 | |
| Right-of-use assets related to operating leases | 5 | 6,551 | 5,247 |
| Intangible assets | 52 | 58 | |
| Other non-current assets | 6,818 | 6,144 | |
| Total non-current assets | 26,334 | 24,071 | |
| Total Assets | $145,895 | $182,986 | |
| Liabilities and shareholders’ equity | |||
| Current liabilities: | |||
| Trade payables | 6 | $18,076 | $23,302 |
| Short-term operating leases | 5 | 232 | 1,144 |
| Current contingencies | 9 | 3,153 | 3,959 |
| Other current liabilities | 6 | 5,023 | 8,934 |
| Total current liabilities | 26,483 | 37,339 | |
| Long-term operating leases | 5 | 6,793 | 4,526 |
| Non-current contingencies | 9 | 965 | 935 |
| Other non-current liabilities | 6 | — | — |
| Total non-current liabilities | 7,758 | 5,461 | |
| Total Liabilities | $34,241 | $42,799 | |
| Shareholders’ equity: | |||
| Ordinary shares, €0.10 par value; 96,434,369 and 96,431,770 shares authorized, and issued as of March 31, 2024 and December 31, 2023, respectively | $10,972 | $10,972 | |
| Additional paid-in capital | 379,426 | 377,468 | |
| Treasury stock, 262,644 and 222,988 ordinary shares as of March 31, 2024 and December 31, 2023, respectively, at cost | (1,325) | (1,263) | |
| Accumulated deficit | (266,207) | (238,862) | |
| Accumulated other comprehensive income | 683 | 742 | |
| Accumulated currency translation effect | (11,897) | (8,871) | |
| Total Shareholders’ equity | 7 | $111,654 | $140,187 |
| Total Liabilities and Shareholders’ equity | $145,895 | $182,986 | |
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)
(amounts in thousands, except share and per share data)
| Three Months Ended March 31, | |||
|---|---|---|---|
| Note | 2024 | 2023 | |
| Operating income | 10 | $1,407 | $2,194 |
| Operating expenses | |||
| Research and development expenses | 11 | (21,403) | (16,037) |
| Sales and marketing expenses | 11 | (758) | (434) |
| General and administrative expenses | 11 | (7,804) | (6,889) |
| Total Operating expenses | (29,964) | (23,359) | |
| Loss from operations | (28,558) | (21,165) | |
| Financial income(expenses) | 13 | 1,261 | 605 |
| Loss before taxes | (27,297) | (20,561) | |
| Income tax (expense) | (48) | — | |
| Net loss | $(27,345) | $(20,561) | |
| Foreign currency translation differences, net of taxes | (3,026) | 3,666 | |
| Actuarial gains (losses) on employee benefits, net of taxes | (59) | (82) | |
| Total comprehensive loss | $(30,429) | $(16,977) | |
| Basic/diluted Net loss per share attributable to shareholders | 15 | $(0.28) | $(0.22) |
| Weighted average shares outstanding used in computing per share amounts: | 96,176,057 | 93,970,598 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.